Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A small molecule reduces both parkinsonism and l-dopa-induced dyskinesia in animal models of Parkinson's disease.

Science translational medicine·2026
Same author

Dystrophic changes of nigrostriatal axons harboring a Synj1 Parkinson mutation suggest catastrophic failure of endocytic mechanisms.

bioRxiv : the preprint server for biology·2026
Same author

Modeling Parkinson's pathology in human iPSC dopaminergic neurons uncovers key mechanisms of Lewy body formation and heterogeneity.

Science advances·2026
Same author

Cholinergic interneuron control of GABAergic circuits targeting spiny projection neurons is disrupted in parkinsonian models.

bioRxiv : the preprint server for biology·2026
Same author

Addressing the Challenges of Translating LRRK2 Biology into Disease-Modifying Therapies: The LRRK2 Investigative Therapeutics Exchange Initiative.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

PD GENEration: An International Parkinson's Disease Genetic Research Study.

medRxiv : the preprint server for health sciences·2026

Related Experiment Video

Updated: May 17, 2025

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
09:27

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

17.2K

Alpha-synuclein seed amplification assays: Data sharing, standardization needed for clinical use.

Hilal A Lashuel1,2,3, D James Surmeier4, Tanya Simuni5

  • 1Institute of Bioengineering, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.

Science Advances
|April 2, 2025
PubMed
Summary

Alpha-synuclein seed amplification assays offer improved neurodegenerative disease diagnosis. Standardized protocols and data sharing frameworks are crucial for their widespread clinical adoption.

More Related Videos

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
12:01

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

Published on: May 30, 2015

10.7K
A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model
08:24

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model

Published on: November 25, 2022

2.1K

Related Experiment Videos

Last Updated: May 17, 2025

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
09:27

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

17.2K
Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
12:01

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

Published on: May 30, 2015

10.7K
A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model
08:24

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model

Published on: November 25, 2022

2.1K

Area of Science:

  • Neuroscience
  • Biomarker Discovery
  • Diagnostic Assays

Background:

  • Alpha-synuclein protein misfolding is implicated in various neurodegenerative diseases.
  • Current diagnostic methods for these conditions often lack sensitivity and specificity.

Purpose of the Study:

  • To highlight the potential of alpha-synuclein seed amplification assays (SAA) for diagnosing neurodegenerative diseases.
  • To identify key requirements for the clinical implementation of SAA.

Main Methods:

  • Review of current literature on alpha-synuclein seed amplification assays.
  • Analysis of factors influencing the standardization and data sharing of diagnostic assays.

Main Results:

  • SAA demonstrate high sensitivity and specificity for detecting pathological alpha-synuclein.
  • A lack of standardized protocols and data sharing hinders widespread adoption.

Conclusions:

  • Alpha-synuclein SAA represent a promising tool for enhancing neurodegenerative disease diagnosis and patient care.
  • Establishing a robust framework for protocol standardization and data sharing is essential for clinical translation.